DR. MARK BRIAN JOHNSON, M.D.
Marriage and Family Therapists at Gold Cir, Omaha, NE
License number
Nebraska 24586
Category
Osteopathic Medicine
Type
Family Medicine
Address
Address
13906 Gold Cir #101, Omaha, NE 68144
Phone
(402) 758-2910
(402) 758-2956 (Fax)
(402) 758-2956 (Fax)
Personal information
See more information about MARK BRIAN JOHNSON at radaris.comName
Address
Phone
1227 182Nd, Pleasant Dale, NE 68423
10626 Ellison Plz, Omaha, NE 68134
1007 48Th St, Omaha, NE 68106
1227 182Nd, Seward, NE 68434
1335 Boswell Ave, Crete, NE 68333
Professional information
Advertising Consultant And Content Strategist
Position:
Chief Advertising and Content Strategist at Mark Johnson Communications, Columnist at AWCI, Contributing Editor at Scranton Gillette Communications, Inc.
Location:
Greater Omaha Area
Industry:
Marketing and Advertising
Work:
Mark Johnson Communications
since Mar 1993
-
Chief Advertising and Content Strategist
AWCI
since Jan 2008
-
Columnist
Scranton Gillette Communications, Inc.
since 1993
-
Contributing Editor
Education:
University of Michigan - Stephen M. Ross School of Business 1984 - 1986
M.B.A., Marketing & Finance Trinity University 1979 - 1983
Bachelor of Science (B.S.), Biology and Sociology
M.B.A., Marketing & Finance Trinity University 1979 - 1983
Bachelor of Science (B.S.), Biology and Sociology
Skills:
Advertising, Content Development, Marketing Communications, Web Content, Brand Development, Content Management, SEO copywriting, White Papers, Ghostwriting, Public Relations, Email Marketing, Blogging, Strategic Planning, Media Relations, Press Kits, Brochures, Web Content Management, Marketing Strategy, Creative Development, Creative Direction, Trade Shows, Corporate Communications, Marketing
Honor & Awards:
Jessie H. Neal Honorable Achievement for Business Journalism
Languages:
French
Sr Account Executive At Sterling Commerce An Ibm Company
Position:
Sr Account Executive at IBM, Sr Account Executive at Sterling Commerce an IBM Company, Account Executive at IBM Software Group at IBM
Location:
Greater Omaha Area
Industry:
Computer Software
Work:
IBM
since 2011
-
Sr Account Executive
Sterling Commerce an IBM Company
since Jun 2010
-
Sr Account Executive
IBM Software Group at IBM
since 2010
-
Account Executive
SAS Institute, Inc.
Jan 2007 - Oct 2009
-
Central Region Manager, Retail/CPG Business Unit
ACI Worldwide
Sep 2000 - Oct 2006
-
VP Retail Sales
ACI Worldwide
May 1995 - Dec 2000
-
Senior Sales Representative
NCR
Apr 1993 - May 1995
-
District Sales Manager
NCR
Mar 1990 - Apr 1993
-
Industry Marketing Manager
NCR
Jun 1981 - Mar 1990
-
Sales Representative
Education:
University of Nebraska at Kearney 1977 - 1981
Gross High School
Gross High School
Mark Johnson
Location:
Greater Omaha Area
Industry:
Professional Training & Coaching
Mark Johnson, Omaha NE - Lawyer
Address:
The BUILDING OMAHA, Omaha, NE 68102
Work:
Kutak Rock LLP
Specialties:
Business Law, Real Estate Law, Commercial Finance, Commercial Leasing, Commercial Lending, Commercial Transactions, Public Finance/Municipal Bond Practice, Real Estate Finance, Sale/Leaseback Transactions, UCC Secured Transactions
Links:
Website
Mark B. Johnson, Omaha NE - Lawyer
Office:
Fullenkamp, Doyle & Jobeun
11440 West Center Rd, Omaha, NE 68144
11440 West Center Rd, Omaha, NE 68144
ISLN:
921118525
Admitted:
2007, Ohio, 2008, Nebraska
University:
University of Nebraska at Lincoln, B.S., Economics, 2004
Law School:
The Ohio State University College of Law, J.D., 2007
Biography:
Formerly with Kutak Rock LLP.
Sales Rep At Lyman Richey Corp
Position:
sales rep at lyman richey corp
Location:
Greater Omaha Area
Industry:
Construction
Work:
lyman richey corp
-
sales rep
High Bone Mass Gene Of 11Q13.3
US Patent:
6770461, Aug 3, 2004
Filed:
Apr 5, 2000
Appl. No.:
09/544398
Inventors:
John P. Carulli - Southboro MA
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Assignee:
Genome Therapeutics Corporation - Waltham MA
Creighton University School of Medicine - Omaha NE
Creighton University School of Medicine - Omaha NE
International Classification:
C12P 2100
US Classification:
435 701, 435325, 4352523, 4353201, 435 711, 435 712
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
Genetic Markers To Detect High Bone Mass
US Patent:
5691153, Nov 25, 1997
Filed:
Sep 6, 1996
Appl. No.:
8/708175
Inventors:
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Donald B. Kimmel - Omaha NE
Guodong Gong - Omaha NE
Susan M. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Donald B. Kimmel - Omaha NE
Guodong Gong - Omaha NE
Susan M. Recker - Omaha NE
Assignee:
Creighton University - Omaha NE
International Classification:
C12Q 168
US Classification:
435 6
Abstract:
The invention provides the chromosome location of an autosomal dominant gene associated with high bone mass. As a result of this localization, the presence of a polymorphism linked to the autosomal dominant gene in a subject can be detected by analyzing human chromosome 11 of the subject for the presence of the polymorphism located about 30 cM around D11S987 and linked to the autosomal dominant gene. The analysis of chromosome 11 can be accomplished by amplifying the polymorphism, separating the amplified polymorphism to generate a polymorphism pattern, and correlating the presence or absence of the polymorphism with the respective presence or absence of the autosomal dominant gene associated with high bone mass.
High Bone Mass Gene Of 11Q13.3
US Patent:
7285400, Oct 23, 2007
Filed:
Dec 10, 2003
Appl. No.:
10/731739
Inventors:
John P. Carulli - Southboro MA, US
Randall D. Little - Newtonville MA, US
Robert R. Recker - Omaha NE, US
Mark L. Johnson - Omaha NE, US
Randall D. Little - Newtonville MA, US
Robert R. Recker - Omaha NE, US
Mark L. Johnson - Omaha NE, US
Assignee:
Genome Therapeutics Corporation - Waltham MA
Creighton University - Omaha NE
Creighton University - Omaha NE
International Classification:
C12P 21/00, C12N 15/63, C12N 15/11
US Classification:
435 701, 4353201, 536 231
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
High Bone Mass Gene Of 11Q13.3
US Patent:
2005014, Jun 30, 2005
Filed:
Apr 29, 2004
Appl. No.:
10/834377
Inventors:
John Carulli - Southboro MA, US
Randall Little - Newtonville MA, US
Robert Recker - Omaha NE, US
Mark Johnson - Omaha NE, US
Randall Little - Newtonville MA, US
Robert Recker - Omaha NE, US
Mark Johnson - Omaha NE, US
Assignee:
Genome Therapeutics Corporation - Waltham MA
Creighton University School of Medicine - Omaha NE
Creighton University School of Medicine - Omaha NE
International Classification:
G01N033/53, G01N033/567, G01N033/569
US Classification:
435007200, 435007310
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.